Trial Profile

Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zoledronic acid (Primary) ; Clodronic acid; Ibandronic acid
Indications Adenocarcinoma; Bone metastases; Early breast cancer
Focus Therapeutic Use

Most Recent Events

12 May 2021 Status changed from active, no longer recruiting to completed.
01 May 2021 Results of an analysis assessing the risk factors for bisphosphonate-associated osteonecrosis of the jaw published in the Supportive Care in Cancer
23 Feb 2021 Planned End Date changed from 1 Jan 2021 to 1 Mar 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com